You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. LIVANOVA PLC

LivaNova PLC XNAS: LIVN

LivaNova PLC Live Share Price Today, Share Analysis and Chart

Strong Performer, Under Radar
Download real time

40.84 0.43 (1.06%)

36.66% Fall from 52W High

691.7K XNAS Volume

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share

LivaNova PLC Key Metrics

Select

Market Capitalization

Below industry Median
2,219.7

PE TTM

High in industry
35.1

PEG TTM

Below industry Median
0.1

Price to Book

Below industry Median
1.7

Institutional holding current Qtr %

High in industry
102.9

Revenue Growth Qtr YoY %

Below industry Median
3.8

Operating Revenue growth TTM %

Below industry Median
8.7

Net Profit Qtr Growth YoY %

High in industry
242.1

Net Profit TTM Growth %

High in industry
260.4

Operating Profit Margin Qtr %

Below industry Median
11.5

Operating Profit Margin TTM %

Below industry Median
10.3

Piotroski Score

High in industry
7

Rel Perf vs Sector quarter%

-17.1

ROE Annual %

Below industry Median
4.9

RoA Annual %

Below industry Median
2.6
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Affordable Valuation
62.8 / 100
Momentum Score
Technically Neutral
35.9 / 100
Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM
Analyst Price Target
62
1Yr Price target upside is 51%
10 analysts

15

S

5

W

5

O

0

T

SWOT Analysis

LivaNova PLC Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26100012501500Actual RevenueAvg. Estimate
Hit

LivaNova PLC's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
1.2
Avg. Estimate
2.1
Low Estimate
1.5
High Estimate
2.4
Current EPS
Avg. Estimate
Hit

EPS is expected to grow by 81.0% in FY25

Consensus Recommendation

11 ANALYST Recommendations
BUY

Created with Highcharts 7.2.23Hold4Buy4Strong Buy

The consensus recommendation from 11 analysts for LivaNova PLC is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

LivaNova PLC Stock Analysis

LivaNova PLC stock analysis with key metrics, changes, and trends.

LivaNova PLC MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$1,253.44 M8.66%positive

Annual Revenue rose 8.66%, in the last year to $1,253.44 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$63.23 M260.39%positive

Annual Net Profit rose 260.39% in the last year to $63.23 M. Its sector's average net profit growth for the last fiscal year was 3.61%.

Price to Earning Ratio35.1-negative

Price to Earning Ratio is 35.1, higher than its sector PE ratio of 31.37.

Stock Price$40.84-19.54%negative

Stock Price fell 19.54% and underperformed its sector by 27.2% in the past year.

Quarterly Revenue$321.83 M3.77%positive

Quarterly Revenue rose 3.77% YoY to $321.83 M. Its sector's average revenue growth YoY for the quarter was 8.58%.

Quarterly Net profit$55.89 M242.07%positive

Quarterly Net profit rose 242.07% YoY to $55.89 M. Its sector's average net profit growth YoY for the quarter was 27.3%.

Debt to Equity Ratio0.51-positive

Debt to Equity Ratio of 0.51 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)4.87 %4.87%negative

Return on Equity(ROE) for the last financial year was 4.87%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding71.58 %4.1%positive

Mutual Fund Holding increased by 4.1% in the last quarter to 71.58.

Promoter Share Holding0.23 %0.01%positive

Promoter Share Holding increased by 0.01% in the most recent quarter to 0.23%.

Interest Coverage Ratio2.4-positive

Interest Coverage Ratio is 2.4, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

Institutional Holding102.91 %3.51%positive

Institutional Holding increased by 3.51% in the last quarter to 102.91.

VIEW LESS


Loading data..

LivaNova PLC - Company Profile

What does LivaNova PLC do?

UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

LivaNova PLC Management structure

All Gross Remunerations are in USD
Mr. William A. Kozy
Chairman of the Board and Interim Chief Executive Officer
-
2024
Gross Remuneration
Year
Ms. Trui Hebbelinck
Chief Human Resources Officer
-
2024
Gross Remuneration
Year
Mr. Alex Shvartsburg
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

LivaNova PLC Board of directors

All Gross Remunerations are in USD
Mr. William A. Kozy
Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Vladimir A. Makatsaria
Chief Executive Officer and Director
-
2024
Gross Remuneration
Year
Mr. Daniel Jeffrey Moore
Independent Director
-
2024
Gross Remuneration
Year
Ms. Susan M. Podlogar
Director
-
2024
Gross Remuneration
Year
Mr. Peter M. Wilver
Independent Director
-
2024
Gross Remuneration
Year
Mr. Todd C. Schermerhorn
Independent Director
-
2024
Gross Remuneration
Year

LivaNova PLC FAQ

How is LivaNova PLC today?
LivaNova PLC today is trading in the green, and is up by 1.06% at 40.84.
LivaNova PLC is currently trading up 1.06% on an intraday basis. In the past week the stock rose 4.56%. stock has been down -14.18% in the past quarter and fell -19.54% in the past year. You can view this in the overview section.